Stephen C. Glover's Net Worth

$28.1 Million

Estimate Recalculated Sep 16, 2024 08:48PM EST

Who is Stephen C. Glover

Stephen C. Glover has an estimated net worth of $28.1 Million. This is based on reported shares across multiple companies, which include ANDRX CORP /DE/, INSMED Inc, PDS Biotechnology Corp, Ambrx Biopharma Inc., ZyVersa Therapeutics, Inc., AURIGA LABORATORIES, INC., and Ambrx Biopharma, Inc..

SEC CIK

Stephen C. Glover's CIK is 0001304406

Past Insider Trading and Trends

2022 was Stephen C. Glover's most active year for acquiring shares with 11 total transactions. Stephen C. Glover's most active month to acquire stocks was the month of May. 2024 was Stephen C. Glover's most active year for disposing of shares, totalling 4 transactions. Stephen C. Glover's most active month to dispose stocks was the month of February. 2021 saw Stephen C. Glover paying a total of $49,997.00 for 14,882 shares, this is the most they've acquired in one year. In 2009 Stephen C. Glover cashed out on 569,811 shares for a total of $337,430.00, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

ANDRX CORP /DE/

SVP Brand Operations
Updated Nov 23, 2004
Form 4
2,389.08%
7.00K
Nov 23, 2004
7.29K
Grant
Nov 19
Form 3/A
Nov 23, 2004
Form 3
Sep 30, 2004
293.00
Showing 3 results

INSMED Inc

President Follow-on Biologics
Updated Apr 02, 2009
Form 4
-12.10%
-165.74K
$1.00
-$337.43K
Apr 02, 2009
1.20M
Options
Mar 31
Form 4
120.49%
457.85K
Jun 02, 2008
837.85K
Grant
May 29
Form 4
80.00K
$0.79
$62.94K
Jun 26, 2007
80.00K
Purchase
Jun 25
Form 3
Jun 26, 2007
Showing 4 results

PDS Biotechnology Corp

Investor
Updated Jun 25, 2024
Form 4
9.00K
Jun 25, 2024
9.00K
Grant
Jun 24
Form 4
9.00K
Jul 17, 2023
9.00K
Grant
Jul 14
Form 4
9.00K
Jun 29, 2022
9.00K
Grant
Jun 28
Form 4
25.70%
14.88K
$8.50
$50.00K
Jun 17, 2021
72.79K
Purchase
Jun 15 - Jun 17
Form 4
9.00K
Jun 25, 2020
9.00K
Grant
Jun 23
Form 4
196.84%
38.40K
$1.30
$49.92K
Feb 19, 2020
57.91K
Grant
Feb 14
Form 4
9.00K
Jul 01, 2019
9.00K
Grant
Jun 28
Form 3
Apr 10, 2019
Showing 8 results

Ambrx Biopharma Inc.

Investor
Updated Jun 09, 2023
Form 4
142.50K
Jun 09, 2023
142.50K
Grant
May 18 - Jun 07
Form 4
210.00K
May 26, 2023
210.00K
Grant
May 18
Form 3
May 19, 2023
Showing 3 results

ZyVersa Therapeutics, Inc.

Chief Executive Officer
Updated Jul 18, 2024
Form 4
1.63K
Jul 18, 2024
1.63K
Grant
May 24
Form 4
86,578.64%
1.50M
Dec 14, 2022
1.50M
Grant
Dec 12
Form 3
Dec 13, 2022
Showing 3 results

AURIGA LABORATORIES, INC.

Investor
Updated Dec 13, 2006
Form 3
Dec 13, 2006
Form 4
7.50%
15.00K
Dec 12, 2006
215.00K
Grant
Dec 10
Showing 2 results

Ambrx Biopharma, Inc.

Investor
Updated Mar 07, 2024
Form 4
-100.00%
-50.36K
Mar 07, 2024
Disposition
Mar 07
Showing 1 results